MORO, J; GRINPELC, A; FARRÉ, PL; DUCA, RB; LACUNZA, E; GRAÑA, KD; SCALISE, GD; DALTON, GN; MASSILLO, C; PICCIONI, F; DIMASE, F; BATAGELJ, E; DE SIERVI, A; DE LUCA, P

miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; Lugar: Basel; Año: 2023 vol. 24 p. 1 - 18

MASSILLO, CINTIA; DALTON, GUILLERMO NICOLÁS; PORRETTI, JULIANA; SCALISE, GEORGINA DANIELA; FARRÉ, PAULA LUCÍA; PICCIONI, FLAVIA; SECCHIARI, FLORENCIA; PASCUALI, NATALIA; CLYNE, COLIN; GARDNER, KEVIN; DE LUCA, PAOLA; DE SIERVI, ADRIANA

CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2019 vol. 144 p. 1115 - 1127

DALTON, GUILLERMO NICOLÁS; MASSILLO, CINTIA; SCALISE, GEORGINA DANIELA; DUCA, ROCÍO; PORRETTI, JULIANA; FARRÉ, PAULA LUCIA; GARDNER, KEVIN; PAEZ, ALEJANDRA; GUERON, GERALDINE; DE LUCA, PAOLA; DE SIERVI, ADRIANA

CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice

Cell Death & Disease; Año: 2019 vol. 10 p. 1 - 12

FARRÉ, PL; SCALISE, GD; DUCA, RB; DALTON, GN; MASSILLO, C; PORRETTI, J; GRAÑA, KD; GARDNER, K; DE LUCA, P*; DE SIERVI, A* (* SIGNIFICA AMBOS CONTRIBUYERON DE IGUAL MANERA AL TRABAJO)

CTBP1 and metabolic syndrome induce an mRNA and miRNA expression profile critical for breast cancer progression and metastasis

Oncotarget; Lugar: Nueva York; Año: 2018 vol. 9 p. 13848 - 13858

PORRETTI, J; DALTON, GN; MASSILLO, C; SCALISE, GD; FARRÉ, PL; ELBLE, R; GEREZ, EN; ACCIALINI, P; CABANILLAS, AM; GARDNER, K; DE LUCA, P; DE SIERVI, A

CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: New York; Año: 2018 vol. 143 p. 897 - 906

MASSILLO, C*; DALTON, NG*; FARRÉ, PL; DE LUCA, P; DE SIERVI, A

Implications of microRNA dysregulation in the development of prostate cancer

REPRODUCTION; Año: 2017 vol. 154 p. 81 - 97

DE LUCA, P; DALTON, GN; SCALISE, GD; MOIOLA, CP; PORRETTI, J; MASSILLO, C; KORDON, E; GARDNER, K; ZALAZAR, F; FLUMIAN, C; TODARO, L; VAZQUEZ, ES; MEISS, R; DE SIERVI, A

CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs

Oncotarget; Lugar: Nueva York; Año: 2016 vol. 7 p. 18798 - 18811

DE LUCA, P; DE SIERVI, A

"Critical role for BRCA1 expression as a marker of chemosensitivity response and prognosis"

FRONTIERS IN BIOSCIENCE-LANDMARK; Lugar: Albertson, NY, USA; Año: 2016 vol. 8 p. 72 - 83

LABANCA, E; DE LUCA, P; GUERON, G; PAEZ, A; MOIOLA, CP; MASSILLO, C; PORRETTI, J; GIUDICE, J; ZALAZAR, F; NAVONE, N; VAZQUEZ, ES; DE SIERVI, A

Association of HO-1 and BRCA1 is critical for the maintenance of cellular homeostasis in prostate cancer

MOLECULAR CANCER RESEARCH; Lugar: Philadelphia; Año: 2015 vol. 13 p. 1455 - 1464

MOIOLA, CP; DE LUCA, P; ZALAZAR, F; COTIGNOLA, J; RODRÍGUEZ-SEGUÍ, SA; GARDNER, K; MEISS, R; VALLECORSA, P; PIGNATARO, O; MASSA, O; VAZQUEZ, ES; DE SIERVI, A

"Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice"

CLINICAL CANCER RESEARCH; Lugar: Philadelphia; Año: 2014 vol. 20 p. 4086 - 4095

PALM, T; HEMMER, K; WINTER, J; FRICKE, IB; TARBASHEVICH, K; SHAKIB, SF; RUDOLPH, IM; HILLJE, AL; DE LUCA, P; BAHNASSAWY, L; MADEL, R; VIEL, T; DE SIERVI, A; JACOBS, AH; DIEDERICHS, S; SCHWAMBORN, JC

"A systemic transcriptome analysis reveals the regulation of neural stem cell maintenance by an E2F1-miRNA feedback loop"

NUCLEIC ACIDS RESEARCH; Año: 2013 vol. 41 p. 3699 - 3712

DE LUCA, P; MOIOLA, CP; ZALAZAR, F; GARDNER, K; VAZQUEZ, ES; DE SIERVI, A

"BRCA1 and p53 regulate critical prostate cancer pathways"

PROSTATE CANCER AND PROSTATIC DISEASES; Año: 2013 vol. 16 p. 233 - 238

ELGUERO, B; GUERON, G; GIUDICE, J; TOSCANI, MA; DE LUCA, P; ZALAZAR, F; COLUCCIO-LESKOW, F; MEISS, R; NAVONE, N; DE SIERVI, A; VAZQUEZ, E

"Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation"

NEOPLASIA; Año: 2012 vol. 14 p. 1043 - 1056

MOIOLA, C; DE LUCA, P; COTIGNOLA, J; GARDNER, K; VAZQUEZ, E; DE SIERVI, A

"Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription"

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY : INTERNATIONAL JOURNAL OF EXPERIMENTAL CELLULAR PHYSIOLOGY, BIOCHEMISTRY, AND PHARMACOLOGY.; Año: 2012 vol. 30 p. 596 - 608

DE LUCA, P; VAZQUEZ, ES; MOIOLA, C; ZALAZAR, F; COTIGNOLA, J; GUERON, G; GARDNER, K; DE SIERVI, A

"BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer"

MOLECULAR CANCER RESEARCH; Año: 2011 vol. 9 p. 1078 - 1090

DE SIERVI, A*; DE LUCA, P*; BYUN, JS*; DI, LJ; FUFA T; HAGGERTY CM; VAZQUEZ E; MOIOLA C; LONGO DL; GARDNER, K (*SIGNIFICA AMBOS CONTRIBUYERON DE IGUAL MANERA AL TRABAJO)

"Transcriptional autoregulation by BRCA1"

CANCER RESEARCH; Año: 2010 vol. 70 p. 532 - 542

MOIOLA, C*; DE LUCA, P*; GARDNER, K; VAZQUEZ, ES; DE SIERVI, A (* SIGNIFICA AMBOS CONTRIBUYERON DE IGUAL MANERA AL TRABAJO)

"Cyclin T1 overexpression induces malignant transformation and tumor growth"

CELL CYCLE; Año: 2010 vol. 9 p. 3119 - 3126

GUERON, G; DE SIERVI, A; FERRANDO, M; SALIERNO, M; DE LUCA, P; ELGUERO, B; MEISS, R; NAVONE, N; VAZQUEZ, E

"Critical role of endogenous heme oxygenase 1 (HO-1) as a tuner of the invasive potential of prostate cancer cells"

MOLECULAR CANCER RESEARCH; Año: 2009 vol. 7 p. 1745 - 1755

DE SIERVI, A; DE LUCA, P; MOIOLA, C; GUERON, G; TONGBAI, R; CHANDRAMOULI, G.V.R.; HAGGERTY, C; DZEKUNOVA, I; PETERSEN, D; KAWASAKI, E; KIL, WJ; LONGO, D; GARDNER, K

"Identification of new Rel/NFkB regulatory networks by focused genome location analysis"

CELL CYCLE; Año: 2009 vol. 8 p. 2093 - 2100

GE, Y; BYUN, JS; DE LUCA, P; GUERON, G; YABE, I; SADIQ, SM; FIGG., WD; QUINTERO, J; HAGGERTY, CM; LI, QQ; DE SIERVI, A; GARDNER, K.

"Combinatorial anti-leukemic dysruption of oxidative homeostasis and mitochondrial stability by the redox reactive Thalidomide 2-(2,4-Difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and Flavopiridol"

MOLECULAR PHARMACOLOGY; Año: 2008 vol. 74 p. 872 - 883